VR Logo

Unrated

Tata India Pharma & HealthCare Fund - Regular Plan download report


1 Lakh

Investment Grown to
₹ 1.85 Lakh

₹ 10000

Monthly SIP Grown to
₹ 4.50 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Tata India Pharma & HealthCare Reg-G -8.87 -0.79 -0.24 3.77 6.02 -3.22 -7.75 22.66 15.54 -- --
S&P BSE Healthcare TRI -11.58 -1.01 -0.47 4.18 5.11 -5.04 -11.02 22.77 13.22 -- --
Equity: Sectoral-Pharma -10.15 -0.92 -0.38 4.10 5.72 -3.81 -8.94 24.30 14.94 -- --
Rank within category 3 9 6 11 6 4 3 7 2 -- --
Number of funds in category 15 16 16 15 15 15 13 9 4 3 3

As on 12-Aug-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Tata India Pharma & HealthCare Fund - Regular Plan  | Invest Online
Unrated
Dec-15 -7.75 22.66 15.54 2.53 529
Nippon India Pharma Fund
Unrated
Jun-04 -9.81 25.69 18.19 1.98 4,620
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -9.16 25.76 -- 2.07 2,503
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -6.77 29.05 -- 2.10 1,738
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -8.37 24.58 12.60 2.13 1,668

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 20.39 01-Apr-2020 - 09-Apr-2020 -11.13 05-Mar-2020 - 12-Mar-2020
Month 31.54 27-Mar-2020 - 27-Apr-2020 -18.44 20-Feb-2020 - 23-Mar-2020
Quarter 37.97 23-Mar-2020 - 22-Jun-2020 -14.66 26-Sep-2016 - 26-Dec-2016
Year 73.72 23-Mar-2020 - 23-Mar-2021 -18.70 08-Sep-2016 - 08-Sep-2017

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Tata India Pharma & HealthCare Reg-G 22.46 18.97 1.00 2.21 0.82 3.09
S&P BSE Healthcare TRI 22.78 22.44 0.86 1.63 -- --
Equity: Sectoral-Pharma 23.87 20.45 1.00 1.96 0.89 3.20
Rank within category 7 2 5 3 2 6
Number of funds in category 9 9 9 9 9 9

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Jul-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 26
Top 10 Stocks (%) 73.36
Top 5 Stocks (%) 51.93
Top 3 Sectors (%) 98.59
Portfolio P/B Ratio 4.02
Portfolio P/E Ratio 30.67

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 42,084 56,506
Giant (%) 16.51 20.17
Large (%) 33.42 35.87
Mid (%) 40.62 36.51
Small (%) 9.46 7.35
Tiny (%) -- 0.54

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 56.35 17.08 9.08 16.27
up Dr. Reddy's Lab Healthcare 23.69 17.99 7.60 11.47
equal Cipla Healthcare 33.32 11.19 0.00 11.19
equal Apollo Hospitals Healthcare 70.15 8.45 1.80 6.72
equal Alkem Laboratories Healthcare 27.10 7.08 0.00 6.29
equal Ipca Laboratories Healthcare 32.68 8.66 4.51 6.01
equal Fortis Healthcare Healthcare 51.42 5.29 0.00 5.29
equal Lupin Healthcare -- 9.83 1.93 3.94
equal JB Chemicals & Pharma Healthcare 38.46 3.45 0.00 3.45
equal Krishna Institute Of Medical Sciences Healthcare 31.80 3.02 0.00 2.75
equal Aurobindo Pharma Healthcare 14.47 9.16 0.00 2.64
equal Divi's Laboratories Healthcare 31.87 10.88 2.47 2.54
equal Healthcare Global Enterprises Healthcare 57.73 2.84 1.31 2.43
equal FDC Healthcare 23.23 2.52 0.00 2.26
equal Procter & Gamble Health Healthcare 39.21 7.21 1.88 2.18
equal Indoco Remedies Healthcare 22.49 3.39 0.00 2.02
equal Abbott India Healthcare 49.31 11.41 0.00 1.93
up Narayana Hrudayalaya Healthcare 36.91 7.17 0.00 1.60
equal Gland Pharma Healthcare 35.72 2.03 0.00 1.52
equal Ajanta Pharma Healthcare 22.92 2.04 0.00 1.41
equal Glenmark Pharma. Healthcare 13.26 1.96 0.00 1.20
equal ICICI Lombard General Insurance Company Insurance 42.62 1.04 0.00 1.04
equal Glaxosmithkline Pharma Healthcare 14.41 1.44 0.00 0.79
equal Sanofi India Healthcare 15.02 4.57 0.00 0.66
equal Syngene International Healthcare 60.47 4.04 0.00 0.58

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Jul-2022

Fund Manager

— Meeta Shetty since 09-Nov-2018

Education: Ms. Shetty is Bachelor in Economics and CFA Charterholder

Experience: Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.

Funds Managed:


-0.79%

Change from previous, NAV as on 12-Aug-2022

Growth: ₹ 16.4187

IDCW: ₹ 16.4187


Investment Strategy

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) 1,000
Min. SIP Investment (₹) 150
Min. No of Cheques 12
Min. Withdrawal (₹) 500
Min. Balance (₹) 500
Lock-in Period Not Applicable
Exit Load 0.25% for redemption within 30 days

Basic Details

Fund House: Tata Mutual Fund
Launch Date: 28-Dec-2015
Return Since Launch: 7.77%
Benchmark: NIFTY Pharma TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 529 Cr (As on 31-Jul-2022)
Expense Ratio: 2.53% (As on 30-Jun-2022)
Risk Grade: --
Return Grade: --
Turnover: 31.41%

Contact Information

AMC: Tata Asset Management Private Ltd

Address: 9th Floor, Mafatlal Centre, Nariman Point, Mumbai - 400021

Phone: 1800-209-0101

Email: [email protected]

Website: http://www.tatamutualfund.com

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

Most-asked mutual fund queries answered

DateFri, 19-Aug-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot